CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment

Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim

Cancer Research and Treatment. 2021;53(4):1195-1203. Published online 2021 February 1 DOI: https://doi.org/10.4143/crt.2020.1337

Real-World Clinical Outcomes and Prognostic Factors for Patients with Advanced Angiosarcoma who Received Systemic Treatment

Changhee Park, Miso Kim, Yoonjin Kwak, Kyung Chul Moon, Se Hyun Kim, Bhumsuk Keam, Yu Jung Kim, Tae Min Kim, Dong-Wan Kim

Cancer Research and Treatment. 2021;53(4):1195-1203

Link1

Link2 Link3

Real-World Outcomes Following First-Line Treatment in Patients with Advanced Ovarian Cancer with Multiple Risk Factors for Disease Progression who Received Maintenance Therapy or Active Surveillance

Dana Chase, Jessica Perhanidis, Divya Gupta, Linda Kalilani, Amanda Golembesky, Antonio González-Martín

Oncology and Therapy. 2023;11(2):245-261

Link1

Link2 Link3

71P Real-world treatment patterns and clinical outcomes for patients who received sintilimab (Sint) in first-line treatment of advanced non-small cell lung cancer (NSCLC) in China: A multicenter retrospective observational study

Y. Yu, L. Shang, Q. Xie, K. Ying, B. Jin, L. Zhang, L. Liu, J. Li, W. Ding

Immuno-Oncology and Technology. 2022;16:100175

Link1 Link2

P-245: Real-world outcomes in multiple myeloma (MM) patients who received subsequent therapy after daratumumab from the PREAMBLE study

James Farrell, Jin Gu, Trong Kim Le

Clinical Lymphoma Myeloma and Leukemia. 2022;22:S170

Link1 Link2

Expediting Discharge in Hospitalized, Adult Patients with Skin and Soft Tissue Infections Who Received Empiric Vancomycin Therapy with Oritavancin: Description of Findings from an Institutional Pathway

Cristen Whittaker, Thomas P. Lodise, Ethan Nhan, Joseph Reilly

Drugs - Real World Outcomes. 2020;7(S1):30-35

Link1

Link2 Link3

Real-world clinical profile, treatment patterns and patient-reported outcomes in a subset of HR+/HER2- advanced breast cancer patients with poor prognostic factors: data from an international study

A. Davie, G. Cuyun Carter, A. Rider, A. Bailey, K. Lewis, G. Price, H. Ostojic, F. Ringeisen, X. Pivot

ESMO Open. 2021;6(4):100226

Link1 Link2

Prognostic factors in patients who received end-of-life chemotherapy for advanced cancer

Shuji Hiramoto, Tomoko Tamaki, Kengo Nagashima, Tetsuo Hori, Ayako Kikuchi, Akira Yoshioka, Akira Inoue

International Journal of Clinical Oncology. 2018;24(4):454-459

Link1

Link2 Link3

EP08.01-002 Real-World Survival Outcomes of Patients with High PD-L1 Advanced NSCLC Who Received Chemo-Immunotherapy vs Immunotherapy

J. Cheng, C. McKay, V.J. Bray, P.Y. Yip, A. Tognela, P.S. Kok

Journal of Thoracic Oncology. 2022;17(9):S334-S335

Link1 Link2

PCN524 EUROPEAN REAL-WORLD TREATMENT PATTERNS OF SYSTEMIC THERAPIES FOR SECOND LINE (2L) HEPATOCELLULAR CARCINOMA (HCC) PATIENTS WHO PREVIOUSLY RECEIVED SORAFENIB

U. Kiiskinen, A. Rider, A. Leith, K. Khela, A. Girvan, I. Nitu, T. Senin, M.H. Jen

Value in Health. 2019;22:S539-S540

Link1 Link2

TCT-206: Real-World Comparison Of Clinical Outcomes Of Patients Who Received New Generation Platinum Chromium Everolimus-Eluting Stent Versus Cobalt Chromium Everolimus-Eluting Stent

Journal of the American College of Cardiology. 2011;58(20):B55

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.